On July 15, 2022, Frederick Muto, a member of the Board of Directors of Ionis Pharmaceuticals, Inc. notified the Company that he is retiring from the Company's Board effective July 15, 2022. Prior to his retirement, Mr. Muto served on the Board's Audit Committee, Compensation Committee, Nominating, Governance and Review Committee and Finance Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.84 USD | +1.87% | +2.27% | -17.30% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.30% | 5.99B | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- IONS Stock
- News Ionis Pharmaceuticals, Inc.
- Frederick Muto Retires from Ionis Pharmaceuticals, Inc., Effective July 15, 2022